Securities code: Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) securities abbreviation: Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) Announcement No.: 2022014 Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093)
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) (hereinafter referred to as “the company”) the term of office of the Fourth Board of supervisors has expired. In order to ensure the normal operation of the board of supervisors, in accordance with the company law, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM and other laws and regulations According to the relevant provisions of the normative documents and the articles of association, the company held a staff congress on March 2, 2022 to elect the staff representative supervisors of the Fifth Board of supervisors. After deliberation by the employee representatives attending the meeting, Ms. Ye Yuping and Mr. Bai Bing were elected as the employee representative supervisors of the Fifth Board of supervisors of the company (their resumes are attached).
Ms. Ye Yuping and Mr. Bai Bing will form the Fifth Board of supervisors together with the shareholder representative supervisors elected by the second extraordinary general meeting of the company in 2022, with a term of office of three years, which is consistent with the term of office of the shareholder representative supervisors elected by the second extraordinary general meeting of the company in 2022, From the date of resolution of the second extraordinary general meeting of shareholders in 2022 to the date of expiration of the term of office of the Fifth Board of supervisors.
It is hereby announced.
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) board of supervisors
March 3, 2022
enclosure:
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) the resume of the candidate for employee representative supervisor of the Fifth Board of supervisors 1. Ye Yuping, female, born in November 1990, has a master’s degree. Chinese nationality, without permanent residency abroad. From April 2015 to July 2016, he served as a consultant of Tianheng Management Consulting Co., Ltd; From August 2016 to February 2017, he served as financial advisor of Haiyin Wealth Management Co., Ltd; From April 2017 to August 2017, he served as a consultant of Jiangsu jindaxin certified public accountants; From September 2017 to now, he has served as the auditor of the company.
Up to now, Ms. Ye Yuping has not directly held the company’s shares and has no relationship with the actual controller of the company, other shareholders holding more than 5% of the company’s shares, other directors, supervisors and senior managers; Not punished by the CSRC and other relevant departments or the stock exchange; There is no case of being placed on file for investigation by judicial organs for suspected crimes or being placed on file for inspection by CSRC for suspected violations of laws and regulations; There are no circumstances specified in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies; He is not the person who has broken his promise; Qualifications that meet the requirements of relevant laws, administrative regulations, departmental rules, normative documents, Shenzhen Stock Exchange GEM Listing Rules and other relevant provisions of the exchange.
2. Bai Bing, male, born in February 1982, college degree. Chinese nationality, without permanent residency abroad. From September 2003 to September 2009, he served as the manager of IT Department of Jiangyin Qixin Textile Co., Ltd; From September 2009 to now, he has served as the manager of the information technology department and the manager of the storage department of the company.
The company’s shareholder Jiangyin huajuying investment enterprise (limited partnership) holds 800000 shares of the company (accounting for 0.59% of the total share capital of the company), and Mr. Bai Bing holds 3.75% of the shares of Jiangyin huajuying investment enterprise (limited partnership). Mr. Bai Bing has no relationship with the actual controller of the company, other shareholders holding more than 5% of the shares of the company, other directors, supervisors and senior managers; Not punished by the CSRC and other relevant departments or the stock exchange; There is no case of being placed on file for investigation by judicial organs for suspected crimes or being placed on file for inspection by CSRC for suspected violations of laws and regulations; There are no circumstances specified in article 3.2.3 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies; He is not the person who has broken his promise; Qualifications that meet the requirements of relevant laws, administrative regulations, departmental rules, normative documents, Shenzhen Stock Exchange GEM Listing Rules and other relevant provisions of the exchange.
